RxDoctor Payments Data

Jennifer Pamfilie, MD

Family Medicine · Hudson, OHNPI 1104817212

Payments from drug & device makers

$270in general payments, 2019–2025

Across 16 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$102
  • AbbVie$58
  • Pfizer$31
  • Merck$25
  • Novartis$20
  • Novo Nordisk$17
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$270100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC6$102
AbbVie3$58
Pfizer2$31
Merck2$25
Novartis1$20
Novo Nordisk1$17
AstraZeneca1$16

How this compares

$270 in reported general payments places this provider in the 40th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$44,550
Medicare patients
167
Services billed
634

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$39,157
OzempicSemaglutide28$38,611
MounjaroTirzepatide35$35,681
JanuviaSitagliptin Phosphate33$28,921
TrulicityDulaglutide11$13,493
XareltoRivaroxaban16$13,316
FarxigaDapagliflozin Propanediol17$9,420
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,330
Levothyroxine Sodium434$4,159
Aripiprazole29$2,117
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen58$2,073
Atorvastatin Calcium322$2,017
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,837
LantusInsulin Glargine,hum.Rec.Anlog11$1,788
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen38$1,711

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$102$49,17446 claims
PfizerEliquis$31$39,15740 claims
Novo NordiskOzempic$17$38,61128 claims
MerckJanuvia$25$28,92133 claims
AstraZenecaFarxiga$16$9,42017 claims
AbbVieSynthroid$58$1,64140 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Hudson

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →